|
FEATURING PRECONFERENCE SESSIONS
|
- The Basic of Compliance Concerns in Negotiating, Implementing, Managing, Auditing and Monitoring Third Party Relationships
- Social Media Compliance Issues
- Responding to Compliance Investigations in the Asia Pacific Region -- An Interactive Workshop
|
|
|
MINI SUMMITS
|
- What is the 'Right Thing'? The Cultural Translation of Compliance
- Compliance Risk Map for Pharma Industry
- Asia Pacific Clinical Trials Compliance Issues
- India Compliance Update
- Fair Market Value Update
- Compliance Capabilities Now and Future: What Matters and Developing Skills
- Asia Pacific Government Raids and Investigations
- Indonesia and Japan Compliance Updates
- Asia Pacific Mergers and Acquisitions and Joint Ventures
- China and Indochina, including Cambodia, Laos, Thailand and Vietnam, Compliance Update
|
|
|
AND PLENARY SESSIONS
|
- Ethical Business Practice for Pharmaceutical Companies in China
- Understanding China's Legal and Regulatory System
- Chinese Domestic Pharma Company Roundtable
- Chinese Compliance Best Practices Roundtable: Results of the RDPAC Compliance Survey
- The Potential Business Impact of Compliance
- Global Anticorruption Update Roundtable
- FCPA and UK Bribery Act Updates
- Roundtable on Best Practices in Auditing and Monitoring Third Party Relationships
- Korean Compliance Update
- Myanmar Compliance Update
- Compliance as a Business Partner of Sales and Marketing
- Global Transparency and Disclosure Roundtable
|
|
ASIA PACIFIC PHARMA CONGRESS IS A
|
|
|
|
KEYNOTE SPEAKERS
|
Reinhard Angelmar, PhD
Salmon and Rameau Fellow of Healthcare, Management Professor of Marketing, INSEAD, Appointments, Sloan School (MIT), Stockholm School of Economics, ESSEC Business School, and Universite Paris Dauphine, Fontainebleau, France |
Eric Baclet
President and General Manager, Lilly China, EBP (Ethical Business Practice) Executive Sponsor, R&D-based Pharmaceutical Association Committee (RDPAC), Former Vice President of Global Marketing, Lilly Neuroscience, Shanghai, China |
Karen Eryou
Director and Head, Quality & Compliance, UCB Pharma - Greater China and SE Asia, Shanghai, China
|
James Finch, Esq.
Partner and Head of Myanmar Office, DFDL/Myanmar Thanlwin Legal Services Ltd., Yangon, Myanmar |
Jane de Lozey, Esq.
Joint Head of Fraud, Serious Fraud Office, London, UK
|
Yong Hu, Esq.
Head, Legal Affairs Department, Sinopharm Group Co. Ltd., Largest Medical and Healthcare Group in China; Directly Managed by State-owned, Assets Supervision and Administration Commission of the State Council (SASAC), Beijing, China |
Mark Mallon, MBA
Regional Vice President Asia Pacific and President China, AstraZeneca, Former Executive Vice-President and Chief Operating Officer, AstraZeneca KK (Japan), Shanghai, China
|
|
|
FEATURING CHINA COMPLIANCE BEST PRACTICES PANEL
|
Jennifer Chen, Esq.
Legal Director, RDPAC, Shanghai, China |
Jane Huang, LLM
Associate Compliance Director, Eli Lilly China, Shanghai, China |
Shine Yao, MIM
Compliance Director, Merck Sharp & Dohme. Shanghai, China
|
Eva Yin
China/HK Compliance Officer, AstraZeneca, Shanghai, China |
John Auerbach, MA
Partner, Fraud Investigation & Dispute Services, Ernst & Young, Shanghai, China (Moderator)
|
|
INDOCHINA COMPLIANCE UPDATE, INCLUDING CAMBODIA,
LAOS, THAILAND AND VIETNAM
|
Praween Chantanakomes, Esq.
Lawyer, Baker & McKenzie, Bangkok, Thailand |
Yee Chung Seck, Esq.
Partner, Baker & McKenzie (Vietnam) Ltd., Ho Chi Minh City, Socialist Republic of Vietnam |
Kitchrat Kontain, LLM, MBA
Managing Director, South East Asia Law Office, Vientiane, Laos
|
Bretton G. Sciaroni, Esq.
Partner, Sciaroni & Associates, Chair, International Business Chamber of Cambodia, Phnom Penh, Cambodia |
Kareena Teh
Partner, Baker & McKenzie, Hong Kong |
Peerapan Tungsuwan, LLM
Partner, Baker & McKenzie, Bangkok, Thailand
|
|
|
JAPAN COMPLIANCE UPDATE
|
Yoshiki Nagase, LLB, LLM
Senior Director, Country-Lead Health Care Compliance Japan, Johnson & Johnson, Former Senior Regulatory Counsel, Asia, Standard & Poor's, Former Deputy Head of Compliance, Bear Stearns, Former Head of Legal & Compliance, ING, Tokyo, Japan |
Kevin Yamaga-Karns, Esq.
Senior Director, Legal and Compliance, Eli Lilly Japan, Hyogo, Japan |
Miho Mizuguchi, LLM
Counsel, Clifford Chance, Tokyo, Japan (Moderator)
|
|
|
INDIA COMPLIANCE UPDATE
|
Sandeep Baldava
Partner, Fraud Investigation & Dispute Services, Ernst & Young, Hyderabad, India |
Trudy Tan
Regional Compliance Director, AstraZeneca, Shanghai, China
|
|
|
THE BASICS OF COMPLIANCE CONCERNS IN NEGOTIATING, IMPLEMENTING AND MANAGING, AUDITING AND MONITORING THIRD PARTY RELATIONSHIPS
|
Mark Bowra
Partner, KPMG Advisory (China) Limited, Shanghai |
Peter Chua
Compliance Director, Asia Pacific, Covidien, Singapore |
Ronald Goon
Senior Director, Business Practices & Compliance, Johnson & Johnson, Singapore
|
Michael Hickman, Esq.
Senior Counsel, Simmons & Simmons, Shanghai |
Marc L. Miller
Partner, KPMG LLP, New York, NY, USA |
Paul Pu
Senior Manager, KPMG Advisory (China) Limited, Shanghai
|
John Tan
Counsel, Reed Smith, Shanghai, China |
Sam Williamson, Esq.
Partner, Kirkland & Ellis International LLP, Shanghai |
Helen HaiXiao Zhang, Esq.
Partner, Zhong Lun Law Firm, Shanghai
|
|
|
BEST PRACTICES IN AUDITING AND MONITORING THIRD PARTY RELATIONSHIPS
|
Gareth Lee, Esq.
Associate General Counsel and Head of Compliance, Asia Pacific, Allergan Inc., Singapore |
Tong Wu, MBA
Vice President, Compliance and Process Improvement, Cardinal Health China, Shanghai, China |
Eva Yin, MBA
China/HK Compliance Officer, AstraZeneca, Shanghai, China
|
Jean Roux
Partner, Forensic Services, PwC, Shanghi, China (Moderator) |
Katherine Wang, JD, LLM
Counsel, Global Life Sciences Practice, Sidley Austin LLP, Shanghai, China (Moderator)
|
|
|
GLOBAL ANTICORRUPTION UPDATE ROUNDTABLE
|
Eugene Chen, Esq.
Partner, Hogan Lovells International LLP, Shanghai, China |
Hwa-Soo Chung, Esq.
Chair, Health Law Group, Kim & Chang Law Firm, Seoul, South Korea |
Landry Guesdon, Esq.
Counsel, Clifford Chance, Tokyo, Japan
|
Vivian Robinson, Esq.
Partner, McGuireWoods; Former General Counsel of the UK Serious Fraud Office; Former Head, QEB Hollis Whiteman Chambers; Recorder of the Crown Court and Treasurer of Inner Temple, London, UK |
Guillaume Roussel
Vice President, Compliance Solutions EMEA, Cegedim, Paris, France
|
Joseph B. Tompkins, Jr.
Partner, Sidley Austin LLP; Former Deputy Chief of the Fraud Section, Criminal Division, United States Department of Justice, Washington, DC, USA |
Ted Acosta, Esq.
Principal, Ernst & Young LLP; Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY, USA and Paris, France (Moderator)
|
|
|
RESPONDING TO GOVERNMENT INVESTIGATIONS/RAIDS
|
Eugene Chen, Esq.
Partner, Hogan Lovells International LLP, Shanghai, China |
Hwa-Soo Chung, Esq.
Chair, Health Law Group, Kim & Chang Law Firm, Seoul, South Korea
|
Wendy L. Wysong, Esq.
Partner, Clifford Chance LLP, Hong Kong |
Hui Chen, Esq.
Senior Corporate Counsel, Asia-Pacific Regional Lead, International Compliance Investigations, Pfizer, New York, NY, USA
|
|
|
RESPONDING TO COMPLIANCE INVESTIGATIONS IN THE ASIA PACIFIC REGION
|
Yunxia (Kate) Yin
Counsel, Ropes & Gray, Hong Kong
|
|
|
COMPLIANCE ISSUES IN ASIA PACIFIC ACQUISITIONS/MERGERS AND JOINT VENTURES
|
Ted Acosta, Esq.
Principal, Ernst & Young LLP; Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY, USA and Paris, France |
Bernice Cheng, Esq.
Executive Counsel, Transactions Compliance, Asia Pacific, GE Corporate; Former General Counsel, GE Aviation, Asia Pacific, Shanghai, China
|
Emma Davies, Esq.
Partner, Clifford Chance LLP, Singapore |
Tom M. Zerull
Regional Director, Asia Pacific, Office of Ethics and Compliance, Abbott, Singapore
|
|
|
COMPLIANCE RISK MAP FOR PHARMA INDUSTRY
|
Sue Egan
Director and Principal Consultant, Sue Egan Associates; Editor, Life Science Compliance; Former Vice President Compliance, AstraZeneca, Great Missenden, Buckinghamshire, UK |
Joanna Gao
Area Compliance Officer, GlaxoSmithKline China/ Hong Kong, Beijing, China |
Kang Zhuang
Finance Director, Controller, Pfizer Investment Co. Ltd., Beijing, China
|
|
|
GLOBAL TRANSPARENCY AND DISCLOSURE ROUNDTABLE
|
Evelyne Lemaire
Director, PwC LLP, Zurich, Switzerland |
Yoshiki Nagase, LLB, LLM
Senior Director, Country-Lead Health Care Compliance Japan, Johnson & Johnson, Former Senior Regulatory Counsel, Asia, Standard & Poor's, Former Deputy Head of Compliance, Bear Stearns, Former Head of Legal & Compliance, ING, Tokyo, Japan
|
Kevin Yamaga-Karns, Esq.
Senior Director, Legal and Compliance, Eli Lilly Japan, Hyogo, Japan |
Jonathon Kellerman
Principal, Pharmaceutical and Life Sciences Advisory Services, PwC LLP, Florham Park, NJ, USA (Moderator)
|
|
|
ASIA PACIFIC CLINICAL TRIALS COMPLIANCE ISSUES
|
Amar Kureishi, MD
Chief Medical Officer and Head of Strategic, Drug Development in Asia-Pacific, Quintiles, Former Global Head of Medical Affairs, Bayer, Singapore |
Anup Kharode
Director, Pharmaceutical R&D Advisory Services, PwC LLP, Philadelphia, PA, USA (Moderator) |
Chen Yang, Esq.
Partner and Head, China Life Sciences Practice, Sidley Austin LLP, Former Legislative Official, Bureau of Legislative Affairs, Chinese State Council, Beijing, China (Moderator)
|
|
|
UNDERSTANDING OFF-LABEL MARKETING IN THE CONTEXT OF COMPLIANCE IN ASIA
|
Yuet-Ming Tham, Esq.
Partner, Sidley Austin LLP, Hong Kong |
Kevin Yamaga-Karns, Esq.
Senior Director, Legal and Compliance, Eli Lilly Japan, Hyogo, Japan
|
|
|
FAIR MARKET VALUE UPDATE
|
Fred Eaton, MBA
Partner, Polaris Management Partners, New York, NY |
Julian Harrison
Senior Director, Ethics and Compliance, Eli Lilly, Indianapolis, IN, USA
|
|
|
SOCIAL MEDIA COMPLIANCE ISSUES
|
Sue Egan
Director and Principal Consultant, Sue Egan Associates; Editor, Life Science Compliance; Former Vice President Compliance, AstraZeneca, Great Missenden, Buckinghamshire, UK |
Erinn Hutchinson
Partner, Global Pharmaceuticals and Life Sciences PwC, Philadelphia, PA, USA |
Mai Tran
Executive Vice President of Health & Wellness, Ruder Finn Asia, Singapore
|
|
|
|
|
REGISTER FOR ASIA PACIFIC HEALTHCARE INDUSTRY TEAM/PCF/RDPAC/IFPMA INDIVIDUAL AND GROUP REGISTRATION DISCOUNT
|
Click here to register.
|
|
|
|
SPONSORED BY:
|
|
The Asia Pacific Healthcare Industry Compliance Team is an ad hoc, voluntary group of Asia Pacific pharmaceutical, medical device and other life sciences company compliance professionals and legal counsel who meet quarterly to discuss legal and compliance issues and best practices.
|
|
COSPONSORED BY:
|
|
The Pharmaceutical Compliance Forum (PCF) is a coalition of senior compliance professionals and legal counsel from more than 50 of the largest research-based pharmaceutical manufacturers. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effective corporate compliance programs.
|
|
|
|
|
OFFICIAL MEDIA PARTNER
|
|
|
CO CHAIRS
|
Manuel Flores
Compliance Director Asia Pacific, Bayer (South East Asia) Pte Ltd, Singapore
|
Gareth Lee, Esq.
Associate General Counsel & Head of Compliance, Asia Pacific, Allergan Inc., Singapore
|
Abdul Luheshi, MBA, PhD
Vice President Health Care Compliance, Asia Pacific, Johnson & Johnson, Singapore
|
Maria "Maru" Quindimil, MBA
AP & China Regional Compliance Officer, Merck Sharp and Domme (Asia Ltd.), Manila, Philippines
|
Shine Yao, MIM
Compliance Director, Merck Sharp & Dohme. Shanghai, China
|
|
GRANTORS:
|
|
DIAMOND
|
|
|
PLATINUM
|
|
|
BRONZE
|
|
|
PRE AND POST CONFERENCE TOURS
|
The Asia Pacific Pharma Congress is pleased to offer 2 city tours to attendees.
Both tours are being offered on Monday the 10th and Friday the 14th of September.
Click here for more information.
|
|
OTHER MEDIA PARTNERS
|
|
|
FREE TRIAL OFFER FOR INSIDE HEALTH POLICY
|
Inside Washington Publishers is offering friends of the Second Asia Pacific Pharma Congress a free four-week trial subscription to their newsletter Inside Health Policy. The free trial includes all regular subscriber services, including an e-mail alert every business day as a reminder of what's been added to the site.
|
|
ASIA PACIFIC PHARMA CONGRESS PLANNING COMMITTEE
|
Manuel Flores
Compliance Director Asia Pacific, Bayer (South East Asia) Pte Ltd, Singapore (Co chair)
Kelly B. Freeman, PhD
Ethics and Compliance Officer, Eli Lilly and Company, Executive Committee Member, Pharmaceutical Compliance Forum, Indianapolis, IN, USA (Co chair)
Gareth Lee, Esq.
Associate General Counsel & Head of Compliance, Asia Pacific, Allergan Inc., Singapore (Co chair)
Abdul Luheshi, MBA, PhD
Vice President Health Care Compliance, Asia Pacific, Johnson & Johnson, Singapore (Co chair)
Maria "Maru" Quindimil, MBA
AP & China Regional Compliance Officer, Merck Sharp and Domme (Asia Ltd.), Manila, Philippines (Co chair)
Shine Yao, MIM
Compliance Director, Merck Sharp & Dohme. Shanghai, China (Co chair)
Ted Acosta, Esq.
Principal, Ernst & Young LLP, New York, NY, USA and Paris, France
Masood Ahmed
Vice President, Regional Compliance Officer- Asia Pacific, sanofi-aventis group, Singapore
Rebecca Allsopp, Esq.
Legal Counsel, sanofi-aventis, Sydney, Australia
Wayne Baker
Senior Vice President and Chief Sales Officer, Advanced Health Media LLC, Bridgewater, NJ, USA
Scott Bass, Esq.
Partner and Chair, Global Life Sciences Team, Sidley Austin LLP, Washington, DC, USA
Jeff Berry
Regional Director, Ethics and Compliance, Asia Pacific & Japan, Abbott, Singapore
Hui Chen, Esq.
Senior Corporate Counsel, Asia-Pacific Regional Lead, International Compliance Investigations, Pfizer, New York, NY, USA
Emma Davies, Esq.
Head of Clifford Chance's Healthcare & Life Sciences Group, Asia, Shanghai, China
Qiao Gangliang, Esq.
Senior Vice President, Siemens Ltd., China, General Counsel & Compliance Officer North East Asia, Beijing, China
Joanna Gao
Area Compliance Officer, China/HK, GlaxoSmithKline Pte Ltd., Beijing, China
Liz MacGillivray
Compliance Director, Corporate Integrity and Compliance, Novartis International AG, Basel, Switzerland
Tamara Music
Manager, Influenza Vaccines & Code Compliance, IFPMA, Geneva, Switzerland
Toon-Lee Ng, MBA
Regional Head of Quality Systems and Compliance, Japan - Asia Pacific, Genzyme, Singapore
Brian Riewerts
Partner, Global Pharmaceuticals and Life Sciences, PwC LLP, Baltimore, MD, USA
Guillaume Roussel
Vice President, Compliance Solutions EMEA, Cegedim, Paris, France
Trudy Tan
Regional Compliance Director, AstraZeneca, Shanghai, China
Rhys Tee
Associate Director, Compliance (APAC), Biogen Idec (Singapore) Pte Ltd, Singapore
Yuet-Ming Tham, Esq.
Partner, Sidley Austin LLP, Hong Kong
Jun Wei, Esq.
Managing Partner, Beijing Office, Hogan Lovells International LLP, Beijing and Shanghai, China
Tong Wu, MBA
Vice President, Compliance and Process Improvement, Cardinal Health China, Shanghai, China
Tom M. Zerull
Regional Director, Asia Pacific, Office of Ethics & Compliance, Abbott, Singapore
|
|
|
OTHER INTERNATIONAL PHARMA CONGRESSES
|
2007 - Brussels, Belgium
2008 - Paris, France
2009 - Rome, Italy
2010 - Berlin, Germany
2011 - Istanbul, Turkey
2011 - Singapore
2012 - Budapest, Hungary
2012 - Shanghai, China
2012 - São Paulo, Brazil
|
|
|
|
|
|
|
